Vaccines for Immune Mediated Diseases
Patients with invulnerable intervened provocative illnesses (IMID) like rheumatoid joint pain (RA), incendiary inside sickness (IBD), or psoriasis, are at expanded gamble of contamination, to some extent on account of the actual infection, however generally as a result of therapy with resistant modulatory or immunosuppressive medications. Disregarding their raised gamble for antibody preventable sickness, immunization inclusion in IMID patients is shockingly low. Albeit the diminished nature of the invulnerable reaction in patients under immunotherapy might contrarily affect immunization viability in this populace, sufficient humoral reaction to inoculation in IMID patients has been shown for Hepatitis B, Influenza, and Pneumococcal immunization.
Related Conference of Vaccines for Immune Mediated Diseases
August 26-27, 2025
6th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 22-23, 2025
6th World Congress on Neuroimmunology and Neuroinfectious Diseases
Amsterdam, Netherlands
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Vaccines for Immune Mediated Diseases Conference Speakers
Recommended Sessions
- Allergy, Hypersensitivity and Asthma
- Auto immune
- Cellular Immunology and Latest Innovations
- Clinical Immunology: Current & Future Research
- Diagnostic And Technological Novelty Of Immunology
- Genetics Immunology & Vaccinology
- Haematopoietic And Lymphoid Malignancies And Immune System Development
- Immunologic Techniques, Microbial Control and Therapeutics
- Immunological Clinical Practices &Trials
- Infectious Diseases, Emerging and Reemerging diseases: Confronting Future Outbreaks
- Neuroimmunology
- Ocular Immunology & Inflammation
- Pediatric Immunology
- Vaccines and Vaccinology
- Vaccines for Immune Mediated Diseases
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Animal Models & Clinical Trials - Vaccines-Immunization-2025 (France)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2025 (France)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Netherlands)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2025 (France)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2025 (France)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2025 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2025 (France)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2025 (France)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Netherlands)
- Epidemiology - European Immunology 2025 (Italy)
- Fish & Poultry Vaccines - Vaccines-Immunization-2025 (France)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- Geriatric Immunization - Vaccines-Immunization-2025 (France)
- HIV Vaccines - Vaccines-Immunization-2025 (France)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Netherlands)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology - European Immunology 2025 (Italy)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Netherlands)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Peadiatric Vaccination - Vaccines-Immunization-2025 (France)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Netherlands)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Travel & Edible Vaccines - Vaccines-Immunization-2025 (France)
- Vaccine Production & Development - Vaccines-Immunization-2025 (France)
- Vaccines - Vaccines-Immunization-2025 (France)
- Vaccines & Autism - Vaccines-Immunization-2025 (France)
- Vaccines against Drugs - Vaccines-Immunization-2025 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2025 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2025 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2025 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2025 (France)
- Viral Immunology - European Immunology 2025 (Italy)